H.R. 1188 · 116th Congress
FLAT Prices Act
- Stage
- In committee
- Sponsor
- Jared Golden
- Introduced
- 2019-02-13
- Latest action
- 2019-02-14 · Referred to the Subcommittee on Health.
Summary
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act
This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.